(-)-BPAP (BPAP, (-)-1-(Benzofuran-2-yl)-2-propylaminopentane) — Research Compounds Library | RetatrutideCompare

Selective catecholaminergic and serotonergic activity enhancer (CAE) developed by Knoll. In rodent studies it amplifies impulse-evoked release of dopamine, noradrenaline, and serotonin at sub-MAO-inhibitory doses; investigated for neuroprotection and mood. No human clinical use.